$MYGN
MYRIAD GENETICS INC

2014 Q2 Form 10-Q Financial Statement

#000119312514186990 Filed on May 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $188.8M $182.9M $156.5M
YoY Change 8.44% 16.91% 20.57%
Cost Of Revenue $31.00M $23.65M $16.46M
YoY Change 40.27% 43.65% 22.26%
Gross Profit $157.8M $159.3M $140.0M
YoY Change 3.82% 13.76% 20.37%
Gross Profit Margin 83.58% 87.07% 89.48%
Selling, General & Admin $84.30M $87.63M $64.60M
YoY Change 17.9% 35.65% 18.1%
% of Gross Profit 53.42% 55.02% 46.14%
Research & Development $20.20M $13.40M $13.62M
YoY Change 38.36% -1.62% 15.87%
% of Gross Profit 12.8% 8.41% 9.73%
Depreciation & Amortization $5.500M $3.500M $2.100M
YoY Change 139.13% 66.67% -8.7%
% of Gross Profit 3.49% 2.2% 1.5%
Operating Expenses $104.5M $101.0M $78.22M
YoY Change 21.37% 29.16% 17.71%
Operating Profit $53.30M $55.29M $57.92M
YoY Change -19.12% -4.54% 25.65%
Interest Expense $200.0K $2.500M $1.400M
YoY Change -84.62% 78.57% 0.0%
% of Operating Profit 0.38% 4.52% 2.42%
Other Income/Expense, Net -$900.0K $2.056M $1.323M
YoY Change 55.4%
Pretax Income $52.60M $57.34M $59.24M
YoY Change -21.73% -3.2% 24.77%
Income Tax $18.90M $20.57M $21.35M
% Of Pretax Income 35.93% 35.88% 36.04%
Net Earnings $33.60M $36.77M $37.89M
YoY Change -23.81% -2.96% 27.95%
Net Earnings / Revenue 17.8% 20.1% 24.22%
Basic Earnings Per Share $0.50 $0.47
Diluted Earnings Per Share $432.4K $0.48 $0.46
COMMON SHARES
Basic Shares Outstanding 74.82M shares 73.82M shares 80.38M shares
Diluted Shares Outstanding 76.37M shares 82.43M shares

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $186.5M $212.2M $336.2M
YoY Change -49.91% -36.88% -0.36%
Cash & Equivalents $64.80M $85.80M $112.3M
Short-Term Investments $121.6M $126.4M $223.8M
Other Short-Term Assets $26.90M $21.20M $9.000M
YoY Change 177.32% 135.56% -51.35%
Inventory $23.90M $18.91M $7.136M
Prepaid Expenses $6.921M $2.307M $1.541M
Receivables $81.90M $82.68M $93.17M
Other Receivables $3.200M $3.226M $2.200M
Total Short-Term Assets $322.4M $338.2M $447.7M
YoY Change -33.39% -24.47% 6.93%
LONG-TERM ASSETS
Property, Plant & Equipment $34.60M $32.67M $26.88M
YoY Change 25.35% 21.54% 11.51%
Goodwill $169.2M $166.7M $56.85M
YoY Change 197.36% 193.31%
Intangibles $205.3M $208.3M $13.53M
YoY Change 1440.14% 1440.08%
Long-Term Investments $84.10M $65.60M $126.1M
YoY Change -47.01% -47.98% -2.47%
Other Assets $5.000M $5.000M $37.00M
YoY Change -61.54% -86.49% 2.78%
Total Long-Term Assets $501.4M $478.3M $281.3M
YoY Change 56.77% 70.0% 0.26%
TOTAL ASSETS
Total Short-Term Assets $322.4M $338.2M $447.7M
Total Long-Term Assets $501.4M $478.3M $281.3M
Total Assets $823.8M $816.4M $729.0M
YoY Change 2.49% 11.99% 4.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.10M $18.94M $12.24M
YoY Change 27.4% 54.72% 54.91%
Accrued Expenses $56.40M $51.10M $38.35M
YoY Change 27.22% 33.25% 38.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $80.60M $72.16M $53.62M
YoY Change 24.94% 34.57% 44.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $13.60M $10.50M
YoY Change -100.0% 29.52% 5.0%
Total Long-Term Liabilities $0.00 $13.60M $10.50M
YoY Change -100.0% 29.52% 5.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.60M $72.16M $53.62M
Total Long-Term Liabilities $0.00 $13.60M $10.50M
Total Liabilities $104.8M $94.18M $64.10M
YoY Change 39.31% 46.94% 36.09%
SHAREHOLDERS EQUITY
Retained Earnings $2.000M $18.87M $2.050M
YoY Change -93.52% 820.24%
Common Stock $700.0K $745.0K $797.0K
YoY Change -13.15% -6.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $719.0M $722.2M $664.9M
YoY Change
Total Liabilities & Shareholders Equity $823.8M $816.4M $729.0M
YoY Change 2.49% 11.99% 4.25%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $33.60M $36.77M $37.89M
YoY Change -23.81% -2.96% 27.95%
Depreciation, Depletion And Amortization $5.500M $3.500M $2.100M
YoY Change 139.13% 66.67% -8.7%
Cash From Operating Activities $40.90M $11.30M $37.40M
YoY Change -35.08% -69.79% -8.11%
INVESTING ACTIVITIES
Capital Expenditures -$4.600M -$1.600M -$1.600M
YoY Change 64.29% 0.0% -20.0%
Acquisitions
YoY Change
Other Investing Activities -$14.30M $100.0K $49.60M
YoY Change -82.52% -99.8% -218.66%
Cash From Investing Activities -$18.90M -$1.500M $48.00M
YoY Change -77.66% -103.13% -209.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -42.10M 3.500M -41.50M
YoY Change -416.54% -108.43% 4511.11%
NET CHANGE
Cash From Operating Activities 40.90M 11.30M 37.40M
Cash From Investing Activities -18.90M -1.500M 48.00M
Cash From Financing Activities -42.10M 3.500M -41.50M
Net Change In Cash -20.10M 13.30M 43.90M
YoY Change 142.17% -69.7% -1197.5%
FREE CASH FLOW
Cash From Operating Activities $40.90M $11.30M $37.40M
Capital Expenditures -$4.600M -$1.600M -$1.600M
Free Cash Flow $45.50M $12.90M $39.00M
YoY Change -30.85% -66.92% -8.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74823792 shares
CY2012Q2 us-gaap Goodwill
Goodwill
56850000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86352000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80577000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.75
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14434970 shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80577000 shares
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
64509000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-424000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10718000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
56595000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
697346000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
18132000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
728594000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30866000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2043000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44334000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7500000
CY2013Q2 us-gaap Liabilities
Liabilities
75227000
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3620000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
806000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
803821000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13000000
CY2013Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
158748000
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
956000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8007000
CY2013Q2 us-gaap Goodwill
Goodwill
56850000
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
531497000
CY2013Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3373000
CY2013Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18294000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13330000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94333000
CY2013Q2 us-gaap Inventory Net
InventoryNet
5007000
CY2013Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84197000
CY2013Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
65903000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27602000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
28632000
CY2013Q2 us-gaap Assets
Assets
803821000
CY2013Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
490652000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104073000
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8530000
CY2013Q2 us-gaap Notes Receivable Net
NotesReceivableNet
21667000
CY2013Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
531064000
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12150000
CY2013Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
16950000
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
268243000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
483992000
CY2013Q2 mygn Indefinite Lived Intangible Assets Gross Excluding Goodwill
IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
4800000
CY2013Q2 mygn Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
154000
CY2013Q2 mygn Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
587000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112323000
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74513000 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.20
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14956094 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
7823794 shares
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
21.86
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74513000 shares
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
72156000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-122000
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13641000
CY2014Q1 us-gaap Goodwill
Goodwill
166746000
CY2014Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
277378000
CY2014Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3226000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
126235000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62868000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
702754000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
18935000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
722242000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18865000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2118000
CY2014Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8387000
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51103000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9750000
CY2014Q1 us-gaap Liabilities
Liabilities
94184000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5254000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
745000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
816426000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5000000
CY2014Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
65555000
CY2014Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2307000
CY2014Q1 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2014Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18654000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
208296000
CY2014Q1 us-gaap Prepaid Taxes
PrepaidTaxes
12360000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82678000
CY2014Q1 us-gaap Inventory Net
InventoryNet
18906000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
65555000
CY2014Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95533000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6529000
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
76879000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32665000
CY2014Q1 us-gaap Assets
Assets
816426000
CY2014Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
195177000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85798000
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
203496000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
46500000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
65345000
CY2014Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
277713000
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
208750000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
4805000 shares
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
470000
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.90
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110866000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4975000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81219000 shares
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8582000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
268000
us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
126291000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4187000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
126360000
CY2014Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
213550000
CY2014Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
126360000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
277713000
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
277378000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
338164000
CY2014Q1 mygn Indefinite Lived Intangible Assets Gross Excluding Goodwill
IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
4800000
CY2014Q1 mygn Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
346000
CY2014Q1 mygn Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
11000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83544000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2325000 shares
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.92
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38 pure
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-473000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
281774000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5020000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-224000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5265000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
416304000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
166049000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-566000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55834000
us-gaap Revenues
Revenues
439050000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
102767000
us-gaap Operating Income Loss
OperatingIncomeLoss
162086000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
75092000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
22746000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-178000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
443820000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
124705000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5265000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
701000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20435000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
299395000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9039000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39125000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
11585000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
25506000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3963000
us-gaap Net Income Loss
NetIncomeLoss
103065000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4438000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1490000
us-gaap Costs And Expenses
CostsAndExpenses
276964000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-93934000
us-gaap Share Based Compensation
ShareBasedCompensation
20435000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23103000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6635000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25971000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
180294000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62984000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
977000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5580000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2097000
us-gaap Cost Of Revenue
CostOfRevenue
45960000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
36374000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
88331000
dei Trading Symbol
TradingSymbol
MYGN
dei Entity Registrant Name
EntityRegistrantName
MYRIAD GENETICS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000899923
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(1)</td> <td align="left" valign="top"><u>Basis of Presentation</u></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the &#x201C;Company&#x201D;) in accordance with U.S. generally accepted accounting principles (&#x201C;GAAP&#x201D;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto for the fiscal year ended June&#xA0;30, 2013, included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended June&#xA0;30, 2013. Operating results for the three and nine months ended March&#xA0;31, 2014 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> Certain reclassifications have been made to prior period amounts to conform to the current period presentation.</p> </div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3308553 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.82
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78332000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2159000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.48
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
1.61
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.37 pure
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
8545000 shares
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2923000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.56
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
149280000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2404256 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
24.40
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6978000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.81
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y5M27D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76173000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
383173 shares
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9653000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
583000
us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
199380000
us-gaap Investment Income Interest
InvestmentIncomeInterest
5190000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
587000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
105451000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
223531000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1827000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1066000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5109000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
12360000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
565335000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3337000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
225312000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17307000
us-gaap Revenues
Revenues
589450000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
142896000
us-gaap Operating Income Loss
OperatingIncomeLoss
221188000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
122316000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
24115000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
837000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
618743000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-52000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
222014000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4124000
us-gaap Net Income Loss
NetIncomeLoss
142593000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10395000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
109896000
us-gaap Costs And Expenses
CostsAndExpenses
368262000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-169749000
us-gaap Share Based Compensation
ShareBasedCompensation
20503000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30968000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8291000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18275000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
242752000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82719000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-77000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2233000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5635000
us-gaap Cost Of Revenue
CostOfRevenue
67842000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5109000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1634000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27432000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
340829000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2194000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47289000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
10379000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
47156000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
67420000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
154594000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82434000 shares
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2059000 shares
CY2013Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.36
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.36 pure
CY2013Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1738000 shares
CY2013Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.35
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5797000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80375000 shares
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
259000
CY2013Q1 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
46384000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1434000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-111000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
148384000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
59241000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-497000
CY2013Q1 us-gaap Revenues
Revenues
156472000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37654000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
57918000
CY2013Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
28622000
CY2013Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
8088000
CY2013Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
158356000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1323000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
37892000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
98554000
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4455000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64602000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21349000
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
16462000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
194000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6731000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13618000
CY2013Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3872000
CY2013Q1 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
13252000
CY2013Q1 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
31571000
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76374000 shares
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2553000 shares
CY2014Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.40
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.36 pure
CY2014Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1554000 shares
CY2014Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.38
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5300000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73821000 shares
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
45000
CY2014Q1 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
47396000
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2498000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-442000
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
176191000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13640000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13397000
CY2014Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
2961000
CY2014Q1 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
12384000
CY2014Q1 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
29506000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
57343000
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-672000
CY2014Q1 us-gaap Revenues
Revenues
182924000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36143000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
55287000
CY2014Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
29173000
CY2014Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
6733000
CY2014Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
188693000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2056000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
36770000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
127637000
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3479000
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87631000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20573000
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
23648000
CY2014Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1146000

Files In Submission

Name View Source Status
0001193125-14-186990-index-headers.html Edgar Link pending
0001193125-14-186990-index.html Edgar Link pending
0001193125-14-186990.txt Edgar Link pending
0001193125-14-186990-xbrl.zip Edgar Link pending
d696313d10q.htm Edgar Link pending
d696313dex311.htm Edgar Link pending
d696313dex312.htm Edgar Link pending
d696313dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mygn-20140331.xml Edgar Link completed
mygn-20140331.xsd Edgar Link pending
mygn-20140331_cal.xml Edgar Link unprocessable
mygn-20140331_def.xml Edgar Link unprocessable
mygn-20140331_lab.xml Edgar Link unprocessable
mygn-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending